Point‐of‐Care Intestinal Ultrasound Impacts Inflammatory Bowel Disease Care and Reduces the Need for Additional Investigations
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.70019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Wei-Lian Tan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Mater Hospital Brisbane, South Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Point-of-Care Systems, Intestines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background and Aim Intestinal ultrasound (IUS) has emerged as a widely used point‐of‐care (POC) tool for guiding inflammatory bowel disease (IBD) treatment. This study aims to assess the impact of POC IUS on clinical decision‐making in IBD.
Methods
We performed a retrospective review of outpatient cases utilizing POC IUS at a tertiary center between October 2021 and March 2023. We established a control group through retrospective case review by two experienced IBD specialists whose management decisions were based solely on clinical presentations, without access to IUS results. These decisions were then compared to those made when IUS information was available to evaluate the impact of IUS on IBD patient care. We assessed the association of variables using χ 2 test.
Results
Among the 447 IUS examinations analyzed, 45% showed active disease. Abnormal IUS prompted management changes in symptomatic patients more often than in asymptomatic ones (67% vs. 35%, p < 0.001). Without IUS data, more investigations were recommended, including stool testing (51% vs. 9%, p < 0.0001), imaging (22% vs. 4%, p < 0.0001), and endoscopy (39% vs. 9%, p < 0.0001). The rates of escalation to corticosteroids (16% vs. 7%, p < 0.0001) and advanced therapy (22% vs. 12%, p < 0.0001) were notably higher in the control group. IUS significantly correlated with fecal calprotectin (FCP) levels ( p < 0.0001), endoscopic disease activity ( p = 0.002), and magnetic resonance (MR) imaging ( p = 0.047).
Conclusion
This study highlights the significant impact of POC IUS in guiding patient management decisions, reducing additional investigations and potential overtreatment. Furthermore, IUS results consistently aligned with findings from FCP, endoscopy, and MR imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Mater Hospital Brisbane, South Brisbane, Queensland, Australia.
- Mater Research Institute, Brisbane, Queensland, Australia.
- Faculty of Medicine, University of Queensland, Queensland, Australia.
ORCID-Profile: Wei-Lian Tan, Jakob Begun
Zitieren
APA
Tan, W. L., Khoo, E., Khaing, M. M., Barr, E., Fernandes, R. G., Pham, H., An, Y. K., & Begun, J. (2025). Point‐of‐Care Intestinal Ultrasound Impacts Inflammatory Bowel Disease Care and Reduces the Need for Additional Investigations. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70019
Vancouver
Tan WL, Khoo E, Khaing MM, Barr E, Fernandes RG, Pham H, et al. Point‐of‐Care Intestinal Ultrasound Impacts Inflammatory Bowel Disease Care and Reduces the Need for Additional Investigations. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.70019
BibTeX
@article{Tan2025,
author = {Tan, Wei-Lian and Khoo, Emi and Khaing, Myat-Myat and Barr, Emily and Fernandes, Richard G and Pham, Hai and An, Yoon-Kyo and Begun, Jakob},
title = {Point‐of‐Care Intestinal Ultrasound Impacts Inflammatory Bowel Disease Care and Reduces the Need for Additional Investigations},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.70019}
}
EUVIMED